These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7995322

  • 1. Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure. Consequence of dose adjustment.
    Neubeck M, Fliser D, Pritsch M, Weisser K, Fliser M, Nussberger J, Ritz E, Mutschler E.
    Eur J Clin Pharmacol; 1994; 46(6):537-43. PubMed ID: 7995322
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, O'Grady P, Yee KF, Liao WC, Mangold B.
    Br J Clin Pharmacol; 2000 Jan; 49(1):23-31. PubMed ID: 10606834
    [Abstract] [Full Text] [Related]

  • 3. The practical assessment of compliance with ACE-inhibitor therapy--a novel approach.
    MacFadyen RJ, Struthers AD.
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):119-24. PubMed ID: 9007680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 9. Lisinopril pharmacokinetics in chronic renal failure.
    Jackson B, Cubela RB, Conway EL, Johnston CI.
    Br J Clin Pharmacol; 1988 Jun; 25(6):719-24. PubMed ID: 2849471
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic-pharmacodynamic model relating lisinopril plasma concentrations to regional hemodynamic effects in healthy volunteers.
    Bellissant E, Nguyen PC, Giudicelli JF.
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):470-8. PubMed ID: 8877596
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K.
    J Cardiovasc Pharmacol; 1987 Sep; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [Abstract] [Full Text] [Related]

  • 12. Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.
    Davidson NC, Coutie WJ, Webb DJ, Struthers AD.
    Heart; 1996 Jun; 75(6):576-81. PubMed ID: 8697160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
    Hernández D, Lacalzada J, Salido E, Linares J, Barragán A, Lorenzo V, Higueras L, Martín B, Rodríguez A, Laynez I, González-Posada JM, Torres A.
    Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
    [Abstract] [Full Text] [Related]

  • 18. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [Abstract] [Full Text] [Related]

  • 19. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [Abstract] [Full Text] [Related]

  • 20. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.